Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 891-900 of 1772 for

Edit search filters
  1. A Study Of KRN23 In Adult Subjects With Tumor-Induced Osteomalacia Or Epidermal Nevus Syndrome

    Rochester, MN

  2. Study Of Orally Administered AG-120 In Subjects With Advanced Hematologic Malignancies With An IDH1 Mutation

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Pembrolizumab And Binimetinib In Treating Patients With Locally Advanced Or Metastatic Triple Negative Breast Cancer

    Jacksonville, FL

  4. Long-term Safety And Effectiveness Study For Participants With Advanced Tumors Who Are Currently On Treatment Or In Follow-up In A Pembrolizumab Trial

    Rochester, MN

  5. Rituximab With Or Without Stem Cell Transplant In Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma In First Complete Remission

    Jacksonville, FL, Rochester, MN

  6. A Study Of Intratumoral Injection Of Autologous Dendritic Cells After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Liver Cancer

    Rochester, MN

  7. A Study To Optimize Endocrine Therapy Through Motivational Interviewing And Text Interventions

    Albert Lea, MN, Rochester, MN

  8. A Study To Determine The Outcomes Of Patients With Localized B Cell Lymphoblastic Lymphoma (B-LLy) When Treated With Standard Risk B-ALL Therapy

    Rochester, MN

  9. A Study To Evaluate The Effectiveness And Safety Of Pembrolizumab Combined With Bacillus Calmette-Guerin In High-Risk Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. (Apex) Bezuclastinib In Patients With Advanced Systemic Mastocytosis

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer